Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

drugs-loaded lipid-polymer hybrid nanoparticles

Based on

1 Articles
2015 Most recent source

Composition

1

5-Fu solution

Type Complex Compound
Formula
Role core
2

methoxy poly(ethylene glycol)-poly(lactic acid)

mPEG-PLA
Type Polymer
Formula
Role layer
3

(S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate

irinotecan Camptosa CPT
Type Single Compound
Formula C33H38N4O6
Role loaded material
4

Oxa solution

Type Complex Compound
Formula
Role layer
5

phospholipids mixture

Type Complex Compound
Formula
Role layer
6

cholesterol

Type Single Compound
Formula C27H46O
Role loaded material

Properties

General physical and chemical properties

Property Value Source
drug encapsulation dependent on drug concentration

More information available to subscribers only.

Or, view sample content

Applications

Area Application Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Method Source
chromatography

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Source
healthy female BALB/c mouse

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • methoxy poly(ethylene glycol)-poly(lactic acid)
  • 5-Fu solution
  • (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate
  1. I0xppjjWXyklazVOr3P5UpNhAZ426ZiKa
  2. 0dKOn
Product

drugs-loaded lipid-polymer hybrid nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial